PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
04-Sep-2024 PulseSight Therapeutics reinforces its scientific leadership in ophthalmology with the establishment of an International Scientific and Clinical Advisory Board PulseSight Therapeutics SAS
04-Sep-2024 Aixial Group Migrates Specific Clinical Data Portfolio Onto Medidata Platform to Create a Single Source of Truth and Accelerate Database Lock Medidata
04-Sep-2024 Prilenia’s Pridopidine for Huntington’s Disease Accepted for European Marketing Authorisation Review Prilenia Therapeutics B.V
04-Sep-2024 NH TherAguix announces continuation of the Phase II NANOBRAINMETS trial in the treatment of brain metastases after completion of a futility analysis NH TherAguix (NHT)
04-Sep-2024 GenesisCare UK appoints Second Doctor Director to UK Board GenesisCare UK
04-Sep-2024 QL Biopharm Announces Abstract on Novel Ultra Long-acting GLP-1RA to be Presented at EASD Annual Meeting 2024 QL Biopharm
04-Sep-2024 SeaBeLife receives Orphan Drug Designation (ODD) from EMA for treatment of acute liver failure SeaBeLife
04-Sep-2024 FDB Recognized as a Top Workplace in San Francisco Bay Area FDB
04-Sep-2024 Lindus Health Launches "All-in-One Ophthalmology CRO" Tailored to Clinical Trials in Ophthalmology Lindus Health
03-Sep-2024 SeaBeLife receives Orphan Drug Designation (ODD) from EMA for treatment of acute liver failure Andrew Lloyd Associates
02-Sep-2024 Theolytics Awarded Significant £2M Transforming Cancer Therapeutics Grant from Innovate UK Theolytics
02-Sep-2024 Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568 Neurocrine Biosciences
02-Sep-2024 Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform Medigene AG
02-Sep-2024 ACG Inspection awarded GS1 Nigeria Gold Partnership ACG Inspection
02-Sep-2024 New Service Center in Veeva Vault CRM Suite Unifies Sales and Service Veeva Systems
30-Aug-2024 Alfa Chemistry Reorganized Its Electroplating Intermediates Supply: Now Over 18 Categories Added Alfa Chemistry
30-Aug-2024 Alfa Chemistry's GPC Center Revolutionizes Analytical Methodologies with Rapid, Easy, and Efficient Services Alfa Chemistry
29-Aug-2024 European Commission approves RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the treatment of adult patients with advanced EGFR-mutated non-small cell lung cancer after failure of prior therapy Janssen-Cilag International NV
29-Aug-2024 Leqembi® (lecanemab) Authorised for Early Alzheimer’s Disease in Great Britain Eisai Europe, Ltd
29-Aug-2024 Alfa Chemistry Announces Supply of Basic Filtration Products to Help Meet Various Filtration Challenges Alfa Chemistry